The health care sector closed the day up 0.5%. K-V Pharmaceutical Company ( KV.A), Cyclacel Pharmaceuticals Inc ( CYCC), K-V Pharmaceutical Company ( KV.B), and Escalon Medical Corporation ( ESMC) were all winners today within the health care sector with Eli Lilly and Company ( LLY) being today's featured health care winner. Eli Lilly and Company rose 39 cents (1%) to $38 on light volume. Throughout the day, 5.8 million shares of Eli Lilly and Company exchanged hands as compared to its average daily volume of 9.8 million shares.

Eli Lilly and Company develops, manufactures, and sells pharmaceutical products worldwide. Eli Lilly and Company has a market cap of $43.6 billion and is part of the drugs industry. The company has a P/E ratio of 8.9, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are up 7.3% year to date as of the close of trading on Wednesday.

TheStreet Ratings rates Eli Lilly and as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Rosetta Genomics ( ROSG), Rosetta Genomics ( ROSGD), Tibet Pharmaceuticals Inc ( TBET), and Medtox Scientific Inc ( MTOX) were all losers within the health care sector with Hospira Inc ( HSP) being today's health care sector Loser Spotlight stock.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).